[Federal Register Volume 65, Number 77 (Thursday, April 20, 2000)]
[Notices]
[Pages 21201-21202]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-9909]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Neurological Devices Panel of the Medical Devices Advisory 
Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Neurological Devices Panel of the Medical 
Devices Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.

[[Page 21202]]

    Date and Time: The meeting will be held on May 11, 2000, 8:30 a.m. 
to 5 p.m.
    Location: Corporate Bldg., conference room 020B, 9200 Corporate 
Blvd., Rockville, MD.
    Contact Person: Janet L. Scudiero, Center for Devices and 
Radiological Health (HFZ-410), Food and Drug Administration, 9200 
Corporate Blvd., Rockville, MD 20850, 301-594-1184, ext. 176, or FDA 
Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in 
the Washington, DC area), code 12513. Please call the Information Line 
or access the Internet address at http://www.fda.gov/cdrh/upadvmtg.html 
for up-to-date information on this meeting.
    Agenda: The committee will discuss, make recommendations and vote 
on a premarket approval application for an embolization device.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by April 24, 
2000. Oral presentations from the public will be scheduled between 
approximately 9 a.m. and 9:30 a.m., and 3 p.m. and 3:30 p.m. Time 
allotted for each presentation may be limited. Those desiring to make 
formal oral presentations should notify the contact person before April 
24, 2000, and submit a brief statement of the general nature of the 
evidence or arguments they wish to present, the names and addresses of 
proposed participants, and an indication of the approximate time 
requested to make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: April 14, 2000.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 00-9909 Filed 4-19-00; 8:45 am]
BILLING CODE 4160-01-F